Skip to content

A prospective study to evaluate the effectiveness of further intraocular pressure (IOP) reduction treatment for normal tension glaucoma

A prospective study to evaluate the effectiveness of further intraocular pressure (IOP) reduction treatment for normal tension glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027850
Enrollment
Unknown
Registered
2019-11-30
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal tension glaucoma

Interventions

treatment group :IOP reduction (drug laser operation)
Natural cause group:Nil

Sponsors

Beijing Tongren Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) diagnosed as normal tension glaucoma; open angle with typical glaucoma optic disc change and retinal nerve fiber layer defect. Glaucomatous visual field damage for at least two consecutive times: at least three continuous scotoma (P < 5%, and at least one P < 1%) can be seen in the semi-lateral visual field. Fixation loss <=20% , false positive rate and false negative rate of visual field examination are required to be <=15%; Before enrolling, 24 h (Goldmann) intraocular pressure monitoring was performed 4 weeks after the cessation of the antihypertensive drugs. 24-hour intraocular pressure in both eyes was <=21mmHg; (2) signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) eye trauma or ophthalmic diseases that affect visual field, such as corneal lesions, cataracts, congenital optic disc abnormalities (such as optic nerve dysplasia above may cause visual field changes similar to glaucoma), retinal arteriovenous occlusion, diabetic retinopathy, retinal detachment, anterior ischemic optic neuropathy, etc.; (2) extremely high myopia (eye axis >=30mm or spherical mirror < -10.00ds), or myopic macular lesions such as choroid retinal fog-like atrophy, paint crack, choroid neovascularization, etc.; (3) the best corrected visual acuity < 0.6, thereby reducing the effect of refractive media opacity, such as cataracts (if cataract surgery was performed before baseline, it was not excluded; if cataracts worsened during the observation period, it was excluded); (4) the mean defect (MD) of the first visual field examination was less than -20.0db, and it was difficult to judge the progress of the severe initial visual field defect; (5) secondary glaucoma; (6) local eye anti-glaucoma surgery, vitrectomy may affect the results of intraocular pressure.

Design outcomes

Primary

MeasureTime frame
IOP;visual field;

Countries

China

Contacts

Public ContactNingli Wang

Beijing Tongren Hospital Affiliated to Capital Medical University

wningli@vip.163.com+86 01058265922

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026